Home > NDARC fact sheet: methadone.

National Drug and Alcohol Research Centre. (2025) NDARC fact sheet: methadone. Sydney: National Drug and Alcohol Research Centre.

[img]
Preview
PDF (Methadone)
1MB

Methadone is a prescription opioid medicine with a range of uses, including treating chronic non-cancer and cancer pain and, more commonly, opioid dependence. It is a common opioid agonist treatment (OAT). Those participating in a methadone treatment program are generally provided with a daily dose of the medicine in an oral solution or syrup, which is swallowed. Methadone is prescribed by a doctor as part of a treatment plan, with the dose and treatment duration based on the needs of the individual.

By providing a regular and stable opioid dose, methadone removes the need for additional opioids and helps to stabilise opioid-dependent individuals. Methadone can also promote changes in the routines and habits that may be associated with the use of heroin or other opioids. This can help a person achieve their treatment goals, which may be to become abstinent, or reduce their opioid use. Opioid dependence treatment using methadone can be long-term, lasting months or years as a form of maintenance therapy, or short-term for approximately five to 14 days to treat withdrawal...

Item Type
FactSheet
Publication Type
International, Report
Drug Type
Opioid
Intervention Type
Drug therapy, Treatment method
Date
May 2025
Publisher
National Drug and Alcohol Research Centre
Corporate Creators
National Drug and Alcohol Research Centre
Place of Publication
Sydney
EndNote
Related (external) link

Repository Staff Only: item control page